Press Releases

    • July 26, 2017

    Nemaura Appoints Dr. Salim Natha to Board of Directors as Independent Director, Chair of Compensation Committee

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    Read more
    July 20, 2017

    Nemaura Signs Letter of Intent for Licensing Agreement with TPM for GCC Region

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    Read more
    July 17, 2017

    Nemaura Appoints Timothy Johnson to Board of Directors as Independent Director, Chairman of Audit and Corporate Governance Committees

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    Read more
    July 10, 2017

    Nemaura Medical Inc. announces uplist to OTCQB

    Nemaura Medical Inc. (OTC: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    Read more
    June 28, 2017

    Nemaura Medical Inc. reports Full Year Financial Results

    Nemaura Medical Inc. (OTC: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    Read more
    June 12, 2017

    Nemaura Medical Inc. reports major improvement in sugarBEAT® sensor performance

    12th June 2017, Loughborough, UK. Nemaura Medical Inc. (OTCBB: NMRD), a medical device company announced the latest version of...

    Read more
    April 24, 2017

    Nemaura Medical Inc. successfully completes development of second-generation sugarBEAT® non-invasive Continuous Glucose Monitoring skin-patch.

    24th April 17, Loughborough, UK. Nemaura Medical Inc. (OTCBB: NMRD), a medical device company has today announced the successful...

    Read more
    February 15, 2017

    Nemaura Medical Inc., to present sugarBEAT® Poster at the Advanced Technologies and Treatments for Diabetes Symposium (ATTD) in Paris, February 16th 2017

    15th February 2017, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD), (“Nemaura”), a medical device company developing a non-invasive,...

    Read more
    September 2, 2016

    Nemaura Medical Inc., sign Letter of Intent with Shenzen CAS Health Corp, for potential JV and manufacture of their sugarBEAT® system

    2nd September 2016, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura” or  the “Company”), a medical device company developing...

    Read more
    August 4, 2016

    Nemaura Medical Inc., completes second FDA Pre-submission meeting and appoints Navigant to submit IDE for Nemaura’s sugarBEAT® system

      4th August 2016, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing a minimally...

    Read more